Exact Mass: 619.105784
Exact Mass Matches: 619.105784
Found 26 metabolites which its exact mass value is equals to given mass value 619.105784
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ADP-L-glycero-D-manno-heptose
An ADP-glycero-D-manno-heptose having L-glycero-configuration at the 6-position of the heptose portion.
Relcovaptan (SR-49059)
NO-Indomethacin
CHLORODICARBONYL[1-(I-PROPYLAMINO)-2,3,4,5-TETRAPHENYLCYCLOPENTADIENYL]RUTHENIUM(II)
C34H28ClNO2Ru (619.0851858000001)
NKP608
NKP608 is a non-peptidic derivative of 4-aminopiperidine which acts as a selective, specific and potent antagonist at the neurokinin-1 (NK-1) receptor both in vitro(IC50=2.6 nM) and in vivo. IC50 value: 2.6 nM Target: NK-1 receptor In vitro, the binding of NKP608 to bovine retina was characterized by an IC50 of 2.6+/-0.4 nM, whereas the compound's affinity to other receptor binding sites, including NK-2 and NK-3, was much lower. Species differences in IC(50) values with NKP608 were less pronounced than with previously described NK-1 receptor antagonists, being 13+/-2 and 27+/-2 nM in gerbil midbrain and rat striatum, respectively. In vivo, using the hind foot thumping model in gerbils, NKP608 exhibited a potent NK-1 antagonistic activity following oral administration (ID(50)=0.23 mg/kg; 2 h pretreatment), supporting a central activity of NKP608. NKP608 may prove a useful anxiolytic compound.
Relcovaptan
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
Glesatinib
C31H27F2N5O3S2 (619.1523296000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
1,2,3-Tri-O-benzoyl-α-L-fucopyranose, Trichloroacetimidate
C29H24Cl3NO8 (619.0567434000001)
[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate
[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate
[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate
[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] (2S,3R,4R,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoate
C16H23N5O17P2 (619.0564168000001)
[[[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] 2,3,4,5-tetrahydroxy-6-oxohexanoate
C16H23N5O17P2 (619.0564168000001)
ADP-L-glycero-beta-D-manno-heptose
An ADP-L-glycero-D-manno-heptose having beta-configuration at the anomeric centre of the heptose.
ADP-D-glycero-beta-D-manno-heptose
The beta-anomer of ADP-D-glycero-D-manno-heptose.
Glutaminase-IN-1
Glutaminase-IN-1 (CB839 derivative), a CB839 derivative, is an allosteric inhibitor of 1,3,4-selenadiazole-containing kidney-type glutaminase (KGA), with an IC50 of 1 nM. Glutaminase-IN-1 (CB839 derivative) shows improved cellular uptake and antitumor activity.